Gastric adenosquamous carcinoma with an apparently pure squamous phenotype on limited biopsy in a patient with HIV: A case report Authors: Mohamed A. Youssef, Zahra Sarrafan Chaharsoughi, Celeste E. Wagner, Hafiz Ghani, Sreeram Parupudi, Ranjana Nawgiri Published: 2026 ABSTRACT Gastric carcinomas with squamous differentiation are exceptionally rare and diagnostically difficult, particularly on limited biopsy material. We report a case of an HIV-positive man in his mid-60s who presented with abdominal pain, melena, and unintentional weight loss. Initial upper endoscopy revealed a large, ulcerated mass involving the gastric fundus and cardia; superficial endoscopic biopsies were non-diagnostic. Endoscopic ultrasound–guided biopsy demonstrated invasive squamous cell carcinoma without a glandular component, and the tumor was staged cT4b cN1 cM0 (clinical Stage IVA, AJCC/UICC eighth edition). The biopsy interpretation was treated as provisional, since sampling of this extent cannot exclude a glandular component. After neoadjuvant FLOT chemotherapy, total gastrectomy with multivisceral resection yielded gastric adenosquamous carcinoma with hepatic metastatic adenocarcinoma, establishing M1 disease and Stage IV. A pure squamous phenotype in a gastric biopsy is therefore not sufficient to diagnose primary gastric squamous cell carcinoma; the distinction rests on the resection specimen. The patient’s HIV infection is relevant background rather than a demonstrated cause. Introduction PGSCC is an exceedingly rare malignancy, accounting for only about 0.04%–0.09% of all gastric cancers. 1 Fewer than 100 cases have been reported. 2 Due to its rarity and often advanced presentation, diagnosis can be challenging, and management is not well established. 3 Gastric adenosquamous carcinoma is equally uncommon and is the principal alternative when squamous differentiation is seen on biopsy, since a small sample may contain only the squamous component. 1 We present the case of an HIV-positive man in his mid-60s with gastric adenosquamous carcinoma that first appeared, on limited biopsy, to be a pure squamous cell carcinoma. Case presentation Clinical history and examination A man in his mid-60s with human immunodeficiency virus (HIV) infection and chronic hepatitis B was admitted to the University of Texas Medical Branch in Galveston in late 2022 with worsening mid-abdominal pain, melena, poor appetite, early satiety, and unintentional weight loss. His HIV was well-controlled on antiretroviral therapy, with a stable CD4 count and an undetectable viral load. We have de-identified all patient details. On physical examination, the patient appeared pale, with tachycardia, orthostatic hypotension, and mild epigastric tenderness. Fecal occult blood testing was positive, and laboratory studies demonstrated iron-deficiency anemia (hemoglobin 7.8 g/dL). Diagnostic work-up Contrast-enhanced computed tomography revealed a 6.7-cm fungating mass centered in the gastric fundus and cardia (Figure 1), with necrosis, transmural extension, suspected invasion of the pancreatic tail, and enlarged perigastric lymph nodes. No definitive distant metastases were identified, and no hepatic lesion was characterized as metastatic on this initial study.Figure 1.Axial view computed tomography of the abdomen revealed a 6.7 cm fungating necrotic mass in the gastric fundus with transmural extension and abutment of the pancreatic tail. Axial view computed tomography of the abdomen revealed a 6.7 cm fungating necrotic mass in the gastric fundus with transmural extension and abutment of the pancreatic tail. Esophagogastroduodenoscopy revealed a large, ulcerated mass occupying the gastric fundus and cardia, with its epicenter approximately 2–5 cm distal to the gastroesophageal junction (GEJ) (Figure 2(A)). The distal esophagus and GEJ appeared grossly normal, without contiguous tumor extension. Initial superficial biopsies demonstrated only reactive gastric mucosa with inflammation.Figure 2.A. Esophagogastroduodenoscopy shows a large, fungating, non-circumferential mass with no bleeding is found in the gastric fundus B. Endosonographically shows a hypoechoic and heterogeneous ulcerated mass in the fundus of the stomach, with clear evidence of transmural invasion into adjacent structures. A. Esophagogastroduodenoscopy shows a large, fungating, non-circumferential mass with no bleeding is found in the gastric fundus B. Endosonographically shows a hypoechoic and heterogeneous ulcerated mass in the fundus of the stomach, with clear evidence of transmural invasion into adjacent structures. Repeat tissue sampling was performed via endoscopic ultrasound (EUS), which revealed a heterogeneous mass with transmural invasion into adjacent structures (Figure 2(B)). The lesion was clinically staged as cT4b cN1 cM0, clinical Stage IVA of the AJCC/UICC TNM staging system for gastric carcinoma (eighth edition), 4 on the basis of suspected pancreatic tail invasion and hypoechoic perigastric nodes; gastric rather than esophageal criteria applied, as the tumor epicenter lay more than 2 cm distal to the GEJ. The cM0 assignment was later revised. Fine-needle aspiration and core needle biopsies were obtained. Pathological findings and immunohistochemistry Histologic examination demonstrated malignant epithelial cells arranged in nests and clusters, with abundant eosinophilic, keratinized cytoplasm and pleomorphic, hyperchromatic nuclei, and foci of keratin pearl formation. No glandular differentiation was identified in this biopsy material despite extensive histologic sectioning (Figure 3(A)).Figure 3.Endoscopic ultrasound–guided biopsy of the gastric mass, showing the squamous component of the tumor. A. The carcinoma consists of nests and sheets of atypical squamous cells with intercellular bridges, hyperchromatic nuclei, and eosinophilic cytoplasm. Keratinization is present. B. p40 is showing nuclear expression of squamous cells. C. CK5/6 immunostaining shows strong cytoplasmic and membranous staining in squamous carcinoma nests. Endoscopic ultrasound–guided biopsy of the gastric mass, showing the squamous component of the tumor. A. The carcinoma consists of nests and sheets of atypical squamous cells with intercellular bridges, hyperchromatic nuclei, and eosinophilic cytoplasm. Keratinization is present. B. p40 is showing nuclear expression of squamous cells. C. CK5/6 immunostaining shows strong cytoplasmic and membranous staining in squamous carcinoma nests. Immunohistochemical studies showed diffuse positivity for p40 and CK5/6 (Figures 3(B) and (C)) and negativity for CK7, CK20, CDX2, and cadherin-17; mucicarmine was negative. This immunoprofile confirmed squamous differentiation in the tissue examined but could not exclude an unsampled glandular component elsewhere within the tumor. In the absence of an esophageal or other primary site, the biopsy was reported as invasive carcinoma with squamous differentiation. The report was qualified as provisional: material of this extent cannot exclude an adenosquamous carcinoma, and the tumor involved the cardia. Treatment plan and molecular profile The patient received neoadjuvant FLOT chemotherapy. 5 Restaging six weeks later demonstrated decreased metabolic tumor volume and an interval decrease in the primary tumor and regional adenopathy, together with a small hepatic lesion that had not been called metastatic before treatment. He then underwent total gastrectomy with multivisceral resection, including splenectomy, distal pancreatectomy, and partial left adrenalectomy. Final surgical pathology demonstrated gastric adenosquamous carcinoma with hepatic metastatic adenocarcinoma. No glandular component had been present in the pre-treatment biopsy; the resection diagnosis therefore replaced the provisional one and excluded primary gastric squamous cell carcinoma, and the hepatic deposit moved the disease from clinical Stage IVA to M1, overall Stage IV (ypTNM). Molecular profiling demonstrated a microsatellite-stable, HER2-negative tumor with low mutational burden and a loss-of-function TGFBR2 variant without an approved targeted therapy. Postoperative assessment and follow-up Postoperative CT showed no residual gross tumor but identified hepatic lesions, and MR confirmed bilobar hepatic metastases not amenable to resection. Adjuvant FLOT was initiated, requiring dose reduction for grade 3 oxaliplatin-induced peripheral neuropathy. With further progression, therapy was transitioned to palliative treatment, complicated by diarrhea, weight loss, and cytopenias. Restaging imaging demonstrated progressive hepatic metastases, and the patient underwent hepatic Y-90 radioembolization followed by percutaneous ablation, with ongoing multidisciplinary follow-up. Discussion PGSCC is an extremely rare malignancy and remains a diagnosis of exclusion; esophageal extension, metastasis from a distant primary, and under sampling in adenosquamous carcinoma must all be excluded. 6 The last of these applies here. No esophageal or alternative primary site was identified, and the biopsy demonstrated a purely squamous phenotype, which pointed initially to PGSCC. Two things told against that reading. The mass involved the cardia, so the Parks criteria were not met in full3,6; and those criteria were framed for resection specimens, in which a glandular component can be excluded, as it cannot be on biopsy material. The gastrectomy specimen bore out both reservations. Under the sixth edition of the World Health Organization classification of digestive system tumours, gastric adenosquamous carcinoma is grouped among carcinomas showing combined squamoid and glandular differentiation, with an arbitrary threshold of at least 20% suggested for each component. 7 Pure PGSCC is a separate and rarer entity requiring the complete absence of a glandular component, which only an adequately sampled resection specimen can establish. Squamous differentiation in these tumors is thought to arise divergently from a glandular precursor rather than de novo. The stage changed during treatment. At presentation the disease was staged cT4b cN1 cM0, clinical Stage IVA 4 ; histologic confirmation of hepatic metastatic adenocarcinoma at resection established M1 disease and overall Stage IV. A hepatic lesion was already measurable six weeks into neoadjuvant therapy, so metastases were most likely present but radiologically occult at diagnosis, and the disease is best regarded as metastatic from the outset (cM1, clinical Stage IVB) and initially understaged. Small-volume liver disease of this kind is easily missed on cross-sectional imaging, and dedicated liver MRI is worth obtaining before a proximal gastric tumor is called non-metastatic. The pathogenesis of gastric carcinomas showing squamous differentiation remains poorly defined; proposed contributors include chronic mucosal injury with squamous metaplasia and oncogenic viruses such as Epstein–Barr virus and human papillomavirus.8,9 HPV involvement was unlikely here, as the tumor was p16 negative, and small foci of squamous metaplasia were identified in the surrounding mucosa. With a glandular component present in the resection specimen, divergent differentiation is the likelier explanation in this patient, and his HIV infection and chronic hepatitis B are best read as background rather than cause.10,11 Initial superficial biopsies demonstrated only inflammatory changes, likely reflecting tumor necrosis and ulceration; such false-negative results are well documented, and several reported cases have been diagnosed only after resection. 12 Endoscopic ultrasound with fine-needle aspiration established the first tissue diagnosis, but it established only what was present in the tissue removed, as the gastrectomy went on to show. Advanced gastric carcinoma with squamous differentiation carries shorter survival than adenocarcinoma. 13 Even well-controlled HIV infection requires attention to infection risk, immune status, and drug–drug interactions with antiretroviral therapy. 14 Conclusion Gastric adenosquamous carcinoma can present as a pure squamous carcinoma on biopsy and evade detection on routine superficial biopsies altogether. Endoscopic ultrasound–guided sampling gave a tissue diagnosis, but only the gastrectomy specimen gave the correct one, showing adenosquamous carcinoma with hepatic metastatic adenocarcinoma and metastatic disease. In retrospect, involvement of the cardia was the clue that the biopsy diagnosis needed confirming. The patient’s history of chronic viral infections is relevant background and no more. Squamous differentiation in a gastric biopsy should be read as provisional until a resection specimen is available. 15